NWF Advisory Services Inc.

Position in ABBV — AbbVie Inc.

CIK 2045735 Los Angeles, CA

Position in ABBV

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$3,227,283

+$474,078 QoQ

Shares Held

12,825

+1.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.59%

of 13F equity value

Holder Rank

#1,601

of 4,153 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

NWF Advisory Services Inc. holds $14,660,430 across 10 Drug Manufacturers - General names. ABBV ranks #1 (22.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc. This page	12,825	$3,227,283
2	LLY	ELI LILLY & Co	2,136	$2,561,982
3	JNJ	Johnson & Johnson	9,493	$2,410,937
4	AMGN	Amgen Inc	5,766	$2,087,983
5	MRK	Merck & Co., Inc.	14,785	$1,899,872
6	PFE	Pfizer Inc	38,937	$937,602
7	AZN	Astrazeneca PLC	3,332	$631,813
8	BMY	Bristol Myers Squibb Co	6,255	$360,413

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,227,283	12,825	+1.3%	Shares	Sole	2026-07-29
2026-03-31	$2,753,205	12,659	-7.3%	Shares	Sole	2026-05-04
2025-12-31	$3,121,401	13,661	+5.3%	Shares	Sole	2026-03-03
2025-09-30	$3,002,610	12,968	-4.0%	Shares	Sole	2025-10-31
2025-06-30	$2,506,612	13,504	+41.2%	Shares	Sole	2025-09-09
2025-03-31	$2,004,058	9,565	-12.8%	Shares	Sole	2025-08-12
2024-12-31	$1,949,724	10,972	+11.9%	Shares	Sole	2025-05-14
2024-09-30	$1,935,896	9,803	+7.8%	Shares	Sole	2025-10-06
2024-06-30	$1,559,288	9,091	+4.4%	Shares	Sole	2025-10-06
2024-03-31	$1,585,726	8,708	+0.4%	Shares	Sole	2025-10-06
2023-12-31	$1,344,519	8,676	-22.3%	Shares	Sole	2025-12-08
2023-09-30	$1,664,553	11,167	-0.8%	Shares	Sole	2025-12-08
2023-06-30	$1,515,981	11,252	0.0%	Shares	Sole	2025-12-08
2023-03-31	$1,793,231	11,252	—	Shares	Sole	2025-12-08
No filing history on record for this holder in this stock.